Refractory Renovascular Hypertension as the Presenting Manifestation of Takayasu Arteritis: A Case Report

Authors

  • Antonio Jiménez-Herrerías Department of Nephrology, Hospital Universitario Virgen de las Nieves, Granada, Spain https://orcid.org/0009-0001-1084-7139
  • Almudena Pérez Marfil Department of Nephrology, Hospital Universitario Virgen de las Nieves, Granada, Spain
  • Elena Delgado Sánchez De Murga Department of Nephrology, Hospital Universitario Virgen de las Nieves, Granada, Spain
  • María José Espigares Huete Department of Nephrology, Hospital Universitario Virgen de las Nieves, Granada, Spain

DOI:

https://doi.org/10.71749/pkj.137

Keywords:

Hypertension, Renovascular, Renal Artery Obstruction, Takayasu Arteritis

Abstract

Takayasu arteritis is a chronic large- vessel vasculitis that may lead to renovascular hypertension and progressive chronic kidney disease. We report the case of a 32- year- old woman presenting with refractory arterial hypertension, declining renal function, and constitutional symptoms. Physical examination revealed marked inter- arm blood pressure asymmetry and reduced left radial pulse. Laboratory investigations showed severe renal impairment, normocytic anemia, and elevated inflammatory markers.

Computed tomography angiography demonstrated diffuse aortic wall thickening, bilateral renal artery stenosis and occlusion of the left subclavian artery. Positron emission tomography confirmed active vascular inflammation, and renal scintigraphy showed severe hypoperfusion of the right kidney. Treatment was initiated with high- dose corticosteroids and methotrexate and later escalated to tocilizumab due to disease relapse. Right renal artery angioplasty was performed for persistent hypertension and renal deterioration.

During long- term follow- up, the patient achieved sustained clinical remission under biologic therapy, stabilisation of chronic kidney disease, and blood pressure control with intensive antihypertensive treatment, including cautious renin- angiotensin system blockade.

This case highlights the importance of early recognition of Takayasu arteritis in young patients with refractory hypertension and supports an individualised multidisciplinary approach combining immunosuppression, selective revascularisation and optimized cardiovascular risk management.

Downloads

Download data is not yet available.

References

Herrmann SM, Textor SC. Renovascular hypertension. Endocrinol Metab Clin North Am. 2019;48:765–78. doi: 10.1016/j.ecl.2019.08.007.

Abumoawad A, Saad A, Ferguson CM, Eirin A, Woollard JR, Herrmann SM, et al. Tissue hypoxia, inflammation, and loss of glomerular filtration rate in human atherosclerotic renovascular disease. Kidney Int. 2019;95:948–57. doi: 10.1016/j.kint.2018.11.039.

Águeda AF, Monti S, Luqmani RA, Buttgereit F, Cid M, Dasgupta B, et al. Management of Takayasu arteritis: a systematic literature review informing the 2018 update of the EULAR recommendation for the management of large vessel vasculitis. RMD Open. 2019;5:e001020. doi: 10.1136/rmdopen-2019-001020.

Grayson PC, Tomasson G, Cuthbertson D, Carette S, Hoffman GS, Khalidi NA, et al. Association of vascular physical examination findings and arteriographic lesions in large vessel vasculitis. J Rheumatol. 2012;39:303–9. doi: 10.3899/jrheum.110652.

Kissin EY, Merkel PA. Diagnostic imaging in Takayasu arteritis. Curr Opin Rheumatol. 2004;16:31–7. doi: 10.1097/00002281-200401000-00007.

Hicks CW, Clark TW, Cooper CJ, de Bhailís ÁM, De Carlo M, Green D, et al. Atherosclerotic Renovascular Disease: A KDIGO (Kidney Disease: Improving Global Outcomes) Controversies Conference. Am J Kidney Dis. 2022;79:289-301. doi: 10.1053/j.ajkd.2021.06.025.

ASTRAL Investigators; Wheatley K, Ives N, Gray R, Kalra PA, Moss JG, et al. Revascularization versus medical therapy for renal-artery stenosis. N Engl J Med. 2009;361:1953-62. doi: 10.1056/NEJMoa0905368.

Schoolwerth AC, Sica DA, Ballermann BJ, Wilcox CS; Council on the Kidney in Cardiovascular Disease and the Council for High Blood Pressure Research of the American Heart Association. Renal considerations in angiotensin converting enzyme inhibitor therapy: a statement for healthcare professionals from the Council on the Kidney in Cardiovascular Disease and the Council for High Blood Pressure Research of the American Heart Association. Circulation. 2001;104:1985-91. doi: 10.1161/hc4101.096153.

Downloads

Published

27-03-2026

Data Availability Statement

The data underlying this case report are available from the corresponding author upon reasonable request, in accordance with patient confidentiality and institutional regulations.

Issue

Section

Case Report

How to Cite

Refractory Renovascular Hypertension as the Presenting Manifestation of Takayasu Arteritis: A Case Report. (2026). Portuguese Kidney Journal. https://doi.org/10.71749/pkj.137

Most read articles by the same author(s)

1 2 3 4 5 6 7 8 9 10 > >> 

Similar Articles

21-30 of 56

You may also start an advanced similarity search for this article.